|
1
|
Ploeg M, Aben KK and Kiemeney LA: The
present and future burden of urinary bladder cancer in the world.
World J Urol. 27:289–293. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Volanis D, Kadiyska T, Galanis A, Delakas
D, Logotheti S and Zoumpourlis V: Environmental factors and genetic
susceptibility promote urinary bladder cancer. Toxicol Lett.
193:131–137. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Marcos-Gragera R, Mallone S, Kiemeney LA,
Vilardell L, Malats N, Allory Y and Sant M: EUROCARE-5 Working
Group: Urinary tract cancer survival in Europe 1999–2007: Results
of the population-based study EUROCARE-5. Eur J Cancer.
51:2217–2230. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mahmoud-Ahmed AS, Suh JH, Kupelian PA,
Klein EA, Peereboom DM, Dreicer R and Barnett GH: Brain metastases
from bladder carcinoma: Presentation, treatment and survival. J
Urol. 167:2419–2422. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mattick JS and Makunin IV: Non-coding RNA.
Human Mol Genet. 15:R17–R29. 2006. View Article : Google Scholar
|
|
6
|
Martens-Uzunova ES, Jalava SE, Dits NF,
van Leenders GJ, Møller S, Trapman J, Bangma CH, Litman T,
Visakorpi T and Jenster G: Diagnostic and prognostic signatures
from the small non-coding RNA transcriptome in prostate cancer.
Oncogene. 31:978–991. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Voorhoeve PM, Le Sage C, Schrier M, Gillis
AJ, Stoop H, Nagel R, Liu YP, van Duijse J, Drost J, Griekspoor A,
et al: A genetic screen implicates miRNA-372 and miRNA-373 as
oncogenes in testicular germ cell tumors. Cell. 124:1169–1181.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Keklikoglou I, Koerner C, Schmidt C, Zhang
JD, Heckmann D, Shavinskaya A, Allgayer H, Gückel B, Fehm T,
Schneeweiss A, et al: MicroRNA-520/373 family functions as a tumor
suppressor in estrogen receptor negative breast cancer by targeting
NF-κB and TGF-β signaling pathways. Oncogene. 31:4150–4163. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Andl CD, Mizushima T, Nakagawa H, Oyama K,
Harada H, Chruma K, Herlyn M and Rustgi AK: Epidermal growth factor
receptor mediates increased cell proliferation, migration, and
aggregation in esophageal keratinocytes in vitro and in vivo. J
Biol Chem. 278:1824–1830. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wei F, Cao C, Xu X and Wang J: Diverse
functions of miR-373 in cancer. J Transl Med. 13:1622015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Crosby ME, Kulshreshtha R, Ivan M and
Glazer PM: MicroRNA regulation of DNA repair gene expression in
hypoxic stress. Cancer Res. 69:1221–1229. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Borovecki F, Lovrecic L, Zhou J, Jeong H,
Then F, Rosas HD, Hersch SM, Hogarth P, Bouzou B, Jensen RV and
Krainc D: Genome-wide expression profiling of human blood reveals
biomarkers for Huntington's disease. Proc Natl Acad Sci USA.
102:11023–11028. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Marczylo EL, Amoako AA, Konje JC, Gant TW
and Marczylo TH: Smoking induces differential miRNA expression in
human spermatozoa: A potential transgenerational epigenetic
concern? Epigenet. 7:432–439. 2012. View Article : Google Scholar
|
|
17
|
Mamdani M, Williamson V, McMichael GO,
Blevins T, Aliev F, Adkins A, Hack L, Bigdeli T, van der Vaart AD,
Web BT, et al: Integrating mRNA and miRNA weighted gene
co-expression networks with eQTLs in the nucleus accumbens of
subjects with alcohol dependence. PLoS One. 10:e01376712015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Olivieri F, Capri M, Bonafè M, Morsiani C,
Jung HJ, Spazzafumo L, Viña J and Suh Y: Circulating miRNAs and
miRNA shuttles as biomarkers: Perspective trajectories of healthy
and unhealthy aging. Mech Ageing Dev. 165:162–170. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang Q, Gumireddy K, Schrier M, le Sage
C, Nagel R, Nair S, Egan DA, Li A, Huang G, Klein-Szanto AJ, et al:
The microRNAs miR-373 and miR-520c promote tumour invasion and
metastasis. Nat Cell Biol. 10:202–210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li X, Zhang Y, Zhang H, Liu X, Gong T, Li
M, Sun L, Ji G, Shi Y, Han Z, et al: miRNA-223 promotes gastric
cancer invasion and metastasis by targeting tumor suppressor
EPB41L3. Mol Cancer Res. 9:824–833. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee KH, Goan YG, Hsiao M, Lee CH, Jian SH,
Lin JT, Chen YL and Lu PJ: MicroRNA-373 (miR-373)
post-transcriptionally regulates large tumor suppressor, homolog 2
(LATS2) and stimulates proliferation in human esophageal cancer.
Exp Cell Res. 315:2529–2538. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Weintraub MD, Vourganti S, Li Q, Apolo AB,
Metwalli AR and Agarwal PK: Targeting the epidermal growth factor
receptor in bladder cancer. J Carcinog Mutag. 4:10–30. 2013.
|
|
23
|
Zhang Q, Wang C, Miao S, Li C, Chen Z and
Li F: Enhancing E-cadherin expression via promoter-targeted miR-373
suppresses bladder cancer cells growth and metastasis. Oncotarget.
8:93969–93983. 2017.PubMed/NCBI
|
